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BET-inhibitionFormany autoimmune diseases, the underlyingmechanism is still unknown. In order to getmore insight into the
etiology of autoimmune diseases, we recently published a study were we performed epigenetic proﬁling and
RNA sequencing on CD4+CD45RO+ T cells derived from the site of inﬂammation of Juvenile Idiopathic Arthritis
(JIA) patients and compared this with healthy controls [1]. In this “Data in Brief”, we focus on the analysis of our
RNA sequencing data reported in this study, of which the raw and processed ﬁles can be found in GEO under
GSE71595.We provide a detailed description of the downstream analysis, quality controls, and different analysis
methods or techniques that validate the results obtained with RNA-sequencing.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).lls/synovial ﬂuid (SF)
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, Utrecht, The Netherlands.1. Direct link to deposited data
The deposited data can be found at: http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE71595.nter for Molecular Medicine,
Netherlands.
. This is an open access article under2. Experimental design, materials and methods
2.1. Study population and sample collection
Four HC and three oligoarticular JIA patients were included who all
had active disease at the time of sampling. SF was collected upon ther-
apeutic joint aspiration and PB was drawn at the same moment.
SFMCs and PBMCs were isolated using Ficoll Isopaque density gradient
centrifugation and were frozen down in FCS containing 10% DMSO.2.2. RNA sample preparation and sequencing
CD4+CD45RO+ cells (ranging between 600.000–1.200.000 cells per
sample) were isolated from frozen HC PBMCs and JIA SFMCs using ﬂow
cytometry, activated with human T-activator CD3/CD28 dynabeads (1
cell: 3 beads) and cultured for 16 h in the presence of 300 nM JQ1(+)
or JQ1(−). Subsequently, cells were treated for 4 h with phorbol
12-myristate 13-acetate (100 ng/ml) and ionomycin (1 μg/mL). Total
RNA was extracted using the RNAeasy kit (Qiagen), according to the
manufacturer's instructions. The quality of the RNA was assessed
based on the RNA proﬁle generated by the bioanalyzer using the
picochip. Removal of rRNA and globin-encodingmRNA, RNA fragmenta-
tion, cDNA generation, adapter ligation and PCR ampliﬁcation was done
using the TruSeq stranded total RNAwith ribo-zero globin sample prep-
aration kit (Illumina) and 75 bp single-end sequencing was performed
using an Illumina NextSeq 500 platform through the Utrecht DNA
sequencing facility.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Quality control steps in RNA-sequencing data analysis. (A) Read quality score across all bases, representative image of one sample is shown. (B) Percentage adapters in reads, rep-
resentative image of one sample is shown. (C) Average percentage of read distribution over DNA regions from untreated 4HC and 3 JIA samples (read distribution is also representative for
JQ1(+) treated samples). (D) Read coverage of housekeeping genes for all samples.
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Read quality assessment, sample demultiplexing, and adapter
trimming was performed by Utrecht DNA sequencing facility using
BaseSpace (Illumina) software. Reads with quality score of Q N 30
were selected for downstream analysis. Before starting downstream
analysis, FastQC (Babraham Bioinformatics) was used to conﬁrm
previous steps (Fig. 1A and B). As a human reference genome, hg19
was used, and reads were mapped to this reference sequence using
Tophat v.2.0.9 [2] with Bowtie 2.1.0 [3] as index (tophat2 -p 8 –
library-type fr-ﬁrststrand –g hg19.gtf). For each sample ± 91% of the
reads were successfully mapped to the genome, indicating sufﬁcient
coverage. RSeQC was used to calculate how mapped reads were
distributed over DNA regions, such as coding sequences and UTRs, and
to assess uniform read coverage of genes [4] (Fig. 1C and D).2.4. Gene expression analysis and validation
Transcriptomes of each individual sample were generated using
CuffLinks v2.2.1 with hg19 gene annotation as a guide [5,6]. Individualtranscripts belonging to the HC or JIA patient group were merged
using Cuffmerge. The resulting transcriptome was used for differen-
tial gene expression analysis using Cuffdiff. Quartile normalization
was performed (–library-norm quartile) to improve the detection
of differential expression of less abundant transcripts. Reads
mapping to rRNA and tRNA were masked (-M option) from the
quantiﬁcation. Cuffnorm was used to generate quartile normalized
count and FPKM tables. Using an FDR ≤ 0.05, 914 transcripts were
identiﬁed that are signiﬁcantly differentially expressed between HC
and JIA patients. Among these transcripts, 637 were upregulated in
JIA patients compared to HC, while 237 were downregulated in JIA
patients. JQ1(+) and JQ1(−) treatments of JIA patient-derived
memory/effector T (Tmem/eff) cells resulted in 633 differential tran-
scripts, based on FDR ≤ 0.05, of which 338 were downregulated upon
JQ1(+) treatment and 295 upregulated.
Principle component analysis (PCA) on the complete transcriptome
of HC and JIA patient-derived T cells, either with and without JQ1(+)
treatment, demonstrated that four different groups can be distin-
guished, illustrating that HC and JIA cluster separately and that JQ1
affects gene expression in such way that treated samples cluster
separately from untreated samples (Fig. 2A).
16 J.G.C. Peeters et al. / Genomics Data 7 (2016) 14–17In addition, we performed PCA on the genes signiﬁcantly expressed
between all different groups, which demonstrated that all replicates
cluster within the same group (Fig. 2B). Initial gene ontology termFig. 2.Validation of RNA-sequencing data analysis. (A) Principal component analysis (PCA)perfo
with either JQ1(−) (HCmin and JIAmin) or JQ1(+) (HCplus and JIAplus). (B) PCA performed
(C) Gene set enrichment analysis (GSEA) on ranked genes differentially expressed between eith
Tmem/eff cells treated with JQ1(−) vs. JQ1(+) treatment. P value was determined using the f
pression of CD38, CD80, CD152, and CD195 in JIA patient-derived Tmem/eff cells upon JQ1(+)
the mean ﬂuorescence intensity of each CD-marker was assessed upon JQ1(+) treatment.analysis revealed that the group of signiﬁcantly genes upregulated in
JIA compared to HC as well as the genes downregulated upon JQ1(+)
treatment in JIA, correlated with a defense response. Additional genermedonwhole transcriptomeof HC and JIA patient-derived CD4+CD45RO+T cells treated
on signiﬁcantly different genes between all replicates within the four groups analyzed.
er HC-derived Tmem/eff cells vs. JIA patient-derived Tmem/eff cells and JIA patient-derived
amilywise error rate procedure. NES = nuclear enrichment score. (D) Relative mRNA ex-
treatment wasmeasured by RNA-sequencing and qPCR. In addition, using ﬂow cytometry,
17J.G.C. Peeters et al. / Genomics Data 7 (2016) 14–17set enrichment analysis (GSEA, Broad Institute) for genes differentially
expressed between HC and JIA showed that the genes positively
correlated with this comparison, i.e. genes that are upregulated in JIA,
are enriched for the same gene subsets as the genes that are negatively
correlated with the comparison JQ1(−) versus JQ1(+) treatment of JIA
patient-derived T cells, i.e. genes that are downregulated by JQ1 (Fig.
2C). This again illustrates that genes affected by JQ1(+) strongly over-
lapwith the genes that are upregulated in JIA. In addition to functionally
grouped network analysis, GSEA also shows that genes associated with
cytokines/cytokine receptor interactions are enrichedwithin this subset
of genes. To further validate our RNA-sequencing results, we selected
some inﬂammation-associated (activation) markers that were
downregulated upon JQ1(+) treatment and measured gene expression
by qPCR. This resulted in the conﬁrmation of downregulation of several
CD markers on the RNA level, of which CD38, CD152, and CD195 also
showed downregulation on the protein level, measured by ﬂow cytom-
etry (Fig. 2D).
3. Conclusion
In order to increase insight into molecular mechanisms playing a
role in autoimmune diseases, we performed genome-wide tran-
scriptome proﬁling of autoinﬂammatory-site derived Tmem/eff cells
obtained from JIA patients. We observed that the majority of genes
differentially expressed between JIA patients and HC were upregulated
in JIA patient-derived T cells, strongly suggesting that these genesmight
contribute to the disease. Furthermore, we treated patient-derived T
cells with the BET-inhibitor JQ1 and observed a preferential inhibition
of the genes that were upregulated in JIA patients, i.e. the disease-
associated genes. RNA-sequencing results were conﬁrmed by qPCRand both PCA and GSEA showed that JQ1 can dramatically alter the
cellular gene expression proﬁle. In conclusion, our data suggests that
BET-inhibition might be a novel, powerful therapeutic strategy in the
treatment of autoimmune diseases.
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